Name
GS1-02 - Efficacy of Pembrolizumab + Chemotherapy vs Placebo + Chemotherapy by PD-L1 Combined Positive Score 1-9, 10-19, and ≥20 for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer
Date & Time
Tuesday, December 7, 2021
Speakers
Virtual Session Link